Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018001 · ClinicalTrials.gov registry record
Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1,057
- Enrollment target
NCT04018001 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1,057 participants.
The verdict
NCT04018001 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1,057 participants
- Enrollment target
Study Summary
The purpose of this study is to compare adherence, persistence, and effectiveness among patients initiating tofacitinib Modified Release (MR) with tofacitinib Immediate Release (IR).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,057 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2019-04-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04018001
The ClinicalTrials.gov registry entry for NCT04018001 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,057 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04018001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04018001 about?
NCT04018001 is a clinical study titled "Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)". The purpose of this study is to compare adherence, persistence, and effectiveness among patients initiating tofacitinib Modified Release (MR) with tofacitinib Immediate Release (IR).
What is the current status of trial NCT04018001?
This trial is currently completed. The enrollment target is 1,057 participants. The study started on 2019-04-12. Estimated completion is 2019-04-25.
Who is sponsoring clinical trial NCT04018001?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.